Skip to main content

CareDx CEO Reg Seeto to Present at AAKP 4th Annual Policy Summit

Written by Customer Service on . Posted in Public Companies.

Reg Seeto will present on technology that enables transplant patient care at the AAKP 2021 Summit

SOUTH SAN FRANCISCO, Calif., June 17, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that Reg Seeto, President and CEO of CareDx, will present “Improving Access to Transplant Care: Telehealth & Technology to Enable Patients Along the Transplant Journey,” at the American Association of Kidney Patients (AAKP) 4th Annual Policy Summit, which will be held virtually on June 17, 2021.

Reg Seeto will be presenting on the growing need for telehealth solutions, accelerated by the COVID-19 pandemic, that has led to innovative solutions like RemoTraC, an at-home blood draw service, AlloCare, a transplant specific patient care app to empower patients to better manage their overall care, and Tx Connect, a cloud-based solution that helps more patients being placed on the referral list for transplant.

“Telehealth has proven to be critically important for transplant patients over the past year, especially with the added risk of COVID-19,” said Reg Seeto, President and CEO, CareDx. “At CareDx, we continue to drive new technologies that improve access to care throughout the patient journey.”

“As a matter of principle, AAKP is a staunch advocate for kidney patient consumer care choice of, and access to, innovations for the timely diagnosis and treatment of kidney diseases, including those delivered by telemedicine,” states Richard Knight, president of AAKP and kidney transplant recipient. “As the premier kidney patient organization in America, with the largest membership of kidney transplant patients, AAKP has carefully analyzed the impact of COVID-19 on the patient community and believes telemedicine and key medical innovations, such as those provided by CareDx, Inc., have set a new standard of care for patient-centered medicine. We are honored to have CareDx CEO Reginald Seeto as a presenter at our National Policy Summit and appreciate the support CareDx has provided since our 2018 Inaugural Summit.”

To learn more about AAKP’s Fourth Annual Policy Summit, visit https://aakp.org/programs-and-events/public-policy-summit/

About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com

Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.